ROXITHROMYCIN IN LYME BORRELIOSIS: DISCREPANT RESULTS OF IN VITRO AND IN VIVO ANIMAL SUSCEPTIBILITY STUDY AND CLINICAL TRIAL IN PATIENTS WITH ERYTHEMA MIGRANS

HANSEN, K., HOVMARK, A., LEBECH, A.M., LEBECH, K., OLSSON, L., & HALKIER, L.. (1992). ROXITHROMYCIN IN LYME BORRELIOSIS: DISCREPANT RESULTS OF IN VITRO AND IN VIVO ANIMAL SUSCEPTIBILITY STUDY AND CLINICAL TRIAL IN PATIENTS WITH ERYTHEMA MIGRANS. ACTA DERMATO VENEREOLOGICA, 72(-), 297-300. SID. https://sid.ir/paper/543686/en

HANSEN K., HOVMARK A., LEBECH A.M., LEBECH K., OLSSON L., HALKIER L.. ROXITHROMYCIN IN LYME BORRELIOSIS: DISCREPANT RESULTS OF IN VITRO AND IN VIVO ANIMAL SUSCEPTIBILITY STUDY AND CLINICAL TRIAL IN PATIENTS WITH ERYTHEMA MIGRANS. ACTA DERMATO VENEREOLOGICA[Internet]. 1992;72(-):297-300. Available from: https://sid.ir/paper/543686/en

K. HANSEN, A. HOVMARK, A.M. LEBECH, K. LEBECH, L. OLSSON, and L. HALKIER, “ROXITHROMYCIN IN LYME BORRELIOSIS: DISCREPANT RESULTS OF IN VITRO AND IN VIVO ANIMAL SUSCEPTIBILITY STUDY AND CLINICAL TRIAL IN PATIENTS WITH ERYTHEMA MIGRANS,” ACTA DERMATO VENEREOLOGICA, vol. 72, no. -, pp. 297–300, 1992, [Online]. Available: https://sid.ir/paper/543686/en